✦ LIBER ✦

PMD31 DECISION-ANALYTIC MODELING IN PARKINSON'S DISEASE

✍ Scribed by U Siebert; B Bornschein; T Walbert; R Dodel

Book ID: 119592963
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 61 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62042-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMD29 A MULTI-OUTCOME DECISION MODEL FOR

PMD29 A MULTI-OUTCOME DECISION MODEL FOR PARKINSON'S DISEASE

✍ U Siebert; B Bornschein; G Sroczynski; A Spottke; R Dodel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Systematic Assessment of Decision Models

Systematic Assessment of Decision Models in Parkinson's Disease

✍ Uwe Siebert; Bernhard Bornschein; Tobias Walbert; Richard C. Dodel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Decision-making in Parkinson's disease

✍ Karsten Witt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Impaired decision-making in Parkinson's

Impaired decision-making in Parkinson's disease

✍ Masaru Mimura; Reiko Oeda; Mitsuru Kawamura 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Decision making in de novo Parkinson's d

Decision making in de novo Parkinson's disease

✍ Michele Poletti; Daniela Frosini; Claudio Lucetti; Paolo Del Dotto; Roberto Cera 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract The aim is to study decision making in patients with de novo Parkinson's disease (PD). Recent studies reported that medicated patients with PD have poor performances compared with age‐matched healthy controls in decision making tasks, specially in the Iowa Gambling Task. Two principal c

Dopamine transporter imaging and SPECT i

Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach

✍ Richard C. Dodel; Helmut Höffken; J. Carsten Möller; Bernhard Bornschein; Thomas 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

As a diagnostic test for patients with suspected Parkinson's disease (PD), single photon emission computed tomography (SPECT) using [ 123 I]FP-CIT tracer has better sensitivity but is more expensive than regular clinical examination (CE). Our objective was to evaluate the clinical and economic impac